Home›Stocks›CTAS

CTAS — structural market context

Cintas Corporation

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 15. Each line shows the earlier value, the later value and their dates.

Price

Close $213.06 (Oct 15) vs $208.63 (Oct 14): +2.12%.

Volume

0.88× its 20-session average (2.0M) on Oct 15.

Includes pre- and post-market trading.

Short interest

Short interest 12.5M shares (settlement Sep 30) vs 11.2M (Sep 15).

No new publication in this window. Latest: settlement Sep 30, published Oct 10.

Fails-to-deliver

Latest file (settlements Sep 1–Sep 14, published Sep 30): 3 days with fails, largest 12K shares on Sep 10.

Previous file (settlements Aug 17–Aug 31, published Sep 16): 4 days with fails, largest 169K shares on Aug 26.

No new publication in this window.

Analyst rating actions

None recorded in this window.

Insider filings (Form 4)

None recorded in this window.

CTAS short interest & days to cover

SHARES SHORT
12.5M
% OF FLOAT
—
DAYS TO COVER
5.3
CHANGE VS PRIOR
+11.6%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (16d ago)

CTAS fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-30 · 16d20$197.74
2026-09-28 · 18d23$199.91
2026-09-25 · 21d5K$197.68

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

CTAS analyst ratings

FirmActionRatingPublished
Argus Researchprice_target—2026-09-29
UBSholdBuy2026-09-24
Robert W. Bairdprice_target—2026-09-24
CitigroupholdSell2026-09-22
BernsteinholdMarket Perform2026-09-10

Rating actions as published by the firms, from public feeds. They are not graded here.

Frequently asked questions

What do analysts say about CTAS?
The most recent action: Argus Research price_target on 2026-09-29. Rating actions are shown as published by the firms; they are not graded here.
Is this page telling me to buy or sell CTAS?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with C

CLF · Cleveland-Cliffs Inc.CAI · Caris Life Sciences, Inc. CommCASY · Casey's General Stores, Inc. CCATX · Perspective Therapeutics, Inc.CBLL · CeriBell, Inc.CHPT · ChargePoint Holdings, Inc.All C →

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.